Future Health ESG Corp. Common stock
FHLT
FHLT was delisted on the 20th of May, 2024.
8 hedge funds and large institutions have $13.3M invested in Future Health ESG Corp. Common stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
16% less capital invested
Capital invested by funds: $15.8M → $13.3M (-$2.5M)
20% less funds holding
Funds holding: 10 → 8 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$3M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$38.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.09K |
| 2 |
Walleye Trading
New York
|
-$10 |
FHLT Hedge Fund Activity: Q1 2023 in Review
8 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Future Health ESG Corp. Common stock (FHLT) for Q1 2023, worth a combined $13.3M — down 16% from $15.8M a quarter earlier.
Fund positioning in FHLT was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was LMR Partners, adding an estimated $3M. The largest seller was UBS Group, exiting entirely with an estimated $7.09K sold.
- 8 institutional investors held Future Health ESG Corp. Common stock (FHLT) as of Q1 2023, down from 10 in Q4 2022.
- Funds reported $13.3M of Future Health ESG Corp. Common stock stock for Q1 2023, down 16% quarter-over-quarter.
- 1 fund opened new Future Health ESG Corp. Common stock positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest Future Health ESG Corp. Common stock buyer in Q1 2023 was LMR Partners, an estimated $3M added.
- The largest Future Health ESG Corp. Common stock seller in Q1 2023 was UBS Group, an estimated $7.09K sold.
Based on aggregated 13F filings for Q1 2023.